Familial hypercholesterolemia: Executive summary of the Japan atherosclerosis society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version
作者： Tamio Teramoto , Jun Sasaki , Shun Ishibashi , Sadatoshi Birou , Hiroyuki Daida
DOI: 10.5551/JAT.20040
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(9)
M Thorogood, M Seed, K De Mott, , Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance British Journal of Obstetrics and Gynaecology. ,vol. 116, pp. 478- 479 ,(2009) , 10.1111/J.1471-0528.2008.02084.X
H Mabuchi, J Koizumi, M Shimizu, R Takeda, Development of coronary heart disease in familial hypercholesterolemia. Circulation. ,vol. 79, pp. 225- 232 ,(1989) , 10.1161/01.CIR.79.2.225
Tomoo Okada, Mitsunori Murata, Kuniaki Yamauchi, Kensuke Harada, New criteria of normal serum lipid levels in Japanese children: the nationwide study. Pediatrics International. ,vol. 44, pp. 596- 601 ,(2002) , 10.1046/J.1442-200X.2002.01634.X
Shizuya Yamashita, Hideaki HBujo, Hidenori Arai, Mariko Harada-Shiba, Shigeyuki Matsui, Masanori Fukushima, Yasushi Saito, Toru Kita, Yuji Matsuzawa, Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan. Journal of Atherosclerosis and Thrombosis. ,vol. 15, pp. 292- 303 ,(2008) , 10.5551/JAT.E610
Nadeem Qureshi, Steve E Humphries, Mary Seed, Philip Rowlands, Rubin Minhas, , Identification and management of familial hypercholesterolaemia: what does it mean to primary care? British Journal of General Practice. ,vol. 59, pp. 773- 778 ,(2009) , 10.3399/BJGP09X472674
Mariko Harada-Shiba, Hidenori Arai, Tomonori Okamura, Koutaro Yokote, Shinichi Oikawa, Atsushi Nohara, Tomoo Okada, Takao Ohta, Hideaki Bujo, Makoto Watanabe, Akihiko Wakatsuki, Shizuya Yamashita, Multicenter Study to Determine the Diagnosis Criteria of Heterozygous Familial Hypercholesterolemia in Japan Journal of Atherosclerosis and Thrombosis. ,vol. 19, pp. 1019- 1026 ,(2012) , 10.5551/JAT.14159
Mariko Harada-Shiba, Takako Sugisawa, Hisashi Makino, Mitsuru Abe, Motoo Tsushima, Yasunao Yoshimasa, Takahiro Yamashita, Yoshihiro Miyamoto, Akira Yamamoto, Hitonobu Tomoike, Shinji Yokoyama, Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. ,vol. 17, pp. 667- 674 ,(2010) , 10.5551/JAT.4143
Mariko Harada-Shiba, Hidenori Arai, Shinichi Oikawa, Takao Ohta, Tomoo Okada, Tomonori Okamura, Atsushi Nohara, Hideaki Bujo, Koutaro Yokote, Akihiko Wakatsuki, Shun Ishibashi, Shizuya Yamashita, Guidelines for the Management of Familial Hypercholesterolemia Journal of Atherosclerosis and Thrombosis. ,vol. 19, pp. 1043- 1060 ,(2012) , 10.5551/JAT.14621
Rae-Ellen W. Kavey, Vivek Allada, Stephen R. Daniels, Laura L. Hayman, Brian W. McCrindle, Jane W. Newburger, Rulan S. Parekh, Julia Steinberger, Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. ,vol. 114, pp. 2710- 2738 ,(2006) , 10.1161/CIRCULATIONAHA.106.179568